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Abstract
Background: Panic disorder (PD) is highly prevalent in patients with non-cardiac chest pain (NCCP). This
study aims to explore the role of psychological factors (PD intensity, anxiety sensitivity, heart-related fear,
attention and avoidance) common to NCCP and PD in predicting chest pain levels in patients with both
conditions.
Methods: This association was investigated in emergency department patients with NCCP and PD receiving
either evidence-based treatment of PD or treatment as usual. Patients were assessed at baseline and
14 weeks later for post-treatment.
Results: Only heart-focused fear and attention for cardiac sensations independently explained a significant
portion of the variance in baseline pain (n = 66). At 3 months follow-up (n = 53), changes in heart-related fear
was the only factor independently associated with changes in chest pain intensity. Even in patients with PD,
fear specific to cardiac sensations seems to play a central role in determining NCCP intensity.
Conclusion: These results suggest that the efficacy of intervention for patients with PD and comorbid NCCP
could be improved by targeting heart-related fear and attention.
Trial registration: NCT00736346
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Background
Non-cardiac chest pain (NCCP) is a very common
motive for medical consultations [1, 2]. Although medic-
ally benign in general, NCCP has major impacts on pa-
tients’ functioning and quality of life, limiting daily living
activities (e.g., household chores, physical activity and
social activity) in as much as 60 % of cases and up to
9 years after initial medical consultation [1, 3–6]. Med-
ical consultations for NCCP cost between eight and 13
billion dollars yearly in the United States [1, 3, 7].
A significant portion of negative outcomes related to
NCCP stems from its comorbidity with PD, which is up
to 11 times more prevalent in patients with NCCP than
in the general population [8–10]. The presence of this
anxiety disorder both increases the risk that NCCP will
become chronic and the negative impacts on patients’
functioning [11–13].
There are several possible explanations for the strong
relationship between PD and NCCP. First, NCCP may
occur during a panic attack [10, 13]. However, although
first-line interventions for PD remain effective in pa-
tients with comorbid NCCP, the effect of such interven-
tions on chest pain appears limited [14]. This could
mean that the reduction in PD symptoms, including
panic attacks, is not sufficient to decrease the intensity
of NCCP. As presented in the major biopsychosocial
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models, NCCP could rather be a true comorbid condi-
tion. Furthermore, these models suggest that the rela-
tionship between NCCP and PD may be attributable to
common mechanisms and vulnerability factors
between both conditions [2, 15]. The most likely psy-
chological mechanisms appear to be anxiety sensitivity
(AS) as well as fear, attention, and avoidance of cardiac
sensations.
In fact, AS—the belief that anxiety symptoms have
negative consequences—seems to be involved in the de-
velopment and maintenance of NCCP and PD [16, 17].
It has been shown that patients with elevated AS have a
lower threshold for pain and an intense fear of pain,
both of which naturally result in negative experiences of
pain [18, 19].
Heart-focused fear represents catastrophic interpreta-
tions of cardiac symptoms [15], which are related with
functioning disturbances in NCCP patients and with
maintenance of PD [20–22]. Furthermore, fear of pain, a
related construct, is strongly associated with excessive
attention to pain and the development of related avoid-
ance behaviors [2, 15, 23–25].
Thus, heart-focused attention is also likely involved in
the development and maintenance of NCCP [2, 15, 23–
25]. This attention to cardiac symptoms contributes to
increase the probability of perceiving symptoms and
experiencing benign physiological fluctuations as dis-
turbing or painful [23]. In the context of PD and NCCP,
heart-focused attention is known to maintain fear of
symptoms as well as avoidance of situations and sensa-
tions [2, 15, 23–25].
Finally, avoidance is a key factor in the maintenance
of PD and NCCP through its impact on fear of symp-
toms [2, 15, 22, 26]. It can also directly affect pain by
promoting physical deconditioning via physical activ-
ity avoidance. In turn, deconditioning tends to exacer-
bate painful physical symptoms, thereby reinforcing
fear and attention, which in turn reinforces avoidance
[27].
To our knowledge, no study to date has specifically ex-
plored the relationships between AS, as well as fear, at-
tention, and avoidance of cardiac sensations in patients
with comorbid PD and NCCP. A clearer understanding
of these relationships is essential to increase the efficacy
of interventions for patients with both conditions.
The first objective of this study is to investigate the re-
lationships between AS, heart-focused fear, attention and
avoidance, as well as panic symptoms, and chest pain
level in patients with comorbid PD and NCCP. The sec-
ond objective is to document the relationships between
changes in AS, heart-focused fear, attention and avoid-
ance, as well as panic symptoms, and reduction in per-
ceived chest pain intensity following evidence-based
intervention for PD or usual care.
Methods
Participants and setting
Patients were recruited from three academic emergency
departments (EDs) between November 2005 and
December 2009 in the course of a larger trial [14]. Patients
aged 18 years or older presenting a chief complaint of
chest pain deemed to be of non-cardiac origin by the ED
physician (i.e., negative serial electrocardiogram and car-
diac enzyme tests, and no identifiable cause on chest radi-
ography) were considered for inclusion in the study. The
inclusion criteria were as follows: fluent in written and
oral English or French and a primary diagnosis of PD.
Patients were excluded if they had a history of cardiac
disease, had received psychological or psychopharma-
cological intervention in the past 6 months, or pre-
sented a condition that could invalidate the interview
(e.g., psychotic state, intoxication, schizophrenia, de-
mentia, cognitive impairment, intellectual deficiency).
Only patients who completed all measures at pre-
intervention were included in the study while
only those who completed post-intervention data were
included in the prospective analysis (objective 2).
Measures
Demographic and medical interview: A structured inter-
view was used to collect sociodemographic data and
medical history.
The Anxiety Disorders Interview Schedule for Diag-
nostic and Statistical Manual of Mental Disorders,
Fourth Edition (ADIS-IV) [28]. This instrument was
used to diagnose PD. The diagnosis reliability of the
ADIS-IV for PD was 92 % in a randomly selected sample
including 30 % of the interviews [14].
The Panic and Agoraphobia Scale (PAS) [29, 30]: This
13-item instrument assesses the severity and frequency
of PD and agoraphobia symptoms over the past week. It
has good internal consistency and satisfactory inter-rater
and test-retest reliability [29, 30].
The Anxiety Sensitivity Index (ASI) [31, 32]: This 16-
item questionnaire measures the tendency to attribute
negative consequences to anxiety symptoms (anxiety sen-
sitivity). This questionnaire has good internal consistency
(α = .82 to .91), good temporal stability, and satisfactory
test-retest reliability [32].
The Short-form McGill Pain Questionnaire, chest pain
version (SF-MPQ-CP) [33]: This 15-item questionnaire
was used to measure subjective chest pain intensity. It
has good internal consistency and very good test-retest
reliability [34].
The Cardiac Anxiety Questionnaire (CAQ) [35]: This
18-item questionnaire measures heart-focused anxiety.
Its three subscales assess heart-focused fear, heart-
focused attention, and avoidance of cardiac sensations.
This questionnaire has good internal consistency (α =
Foldes-Busque et al. BioPsychoSocial Medicine  (2016) 10:30 Page 2 of 8
0.83) and satisfactory convergent validity [35, 36]. Each
of the three CAQ subscales was analyzed independently.
Procedure
Graduate students in clinical psychology assessed NCCP pa-
tients in each of the three sites. PD and other disorders were
evaluated using the ADIS-IV [28]. Eligible patients were
subsequently invited to complete the pre-intervention as-
sessment and were assigned to one of four conditions (one
session of cognitive-behavioral therapy [CBT], seven ses-
sions of CBT, pharmacological intervention with paroxetine,
or treatment as usual as ordered by ED physician) using a
randomized cohort design [14]. Intervention conditions (co-
horts) were randomized rather than individuals according to
a predetermined sequence, allowing each cohort to be re-
cruited during multiple 3-month periods. All patients were
invited for assessment 14 weeks after intervention initiation.
The detailed procedure has been published elsewhere [14].
Statistical analyses
Two groups of patients were created. The first group in-
cluded the entire sample (cross-sectional sample); the
second included only patients with post-intervention
data (prospective sample). This approach was chosen
as 18.5 % of patients presented missing data. Analyses
of variance were conducted to compare patients with
post-intervention data with patients without post-
intervention data on continuous variables. Compari-
sons on categorical variables were conducted with χ2
test or Fisher’s exact test.
For the first objective, a Pearson’s correlation matrix
was generated to identify factors significantly related to
chest pain in the cross-sectional sample among AS,
components of heart-focused anxiety, PD intensity and
age. All variables significantly associated with SF-MPQ-
CP scores were entered in the first step of a hierarchical
linear regression analysis to determine their independent
contribution to pain level. As a second step, sex was
added to the model, as it has been shown to influence
how AS relates to NCCP [37].
For the second objective, change scores were created
to establish relationships between changes on the ASI,
PAS, CAQ subscales, and SF-MPQ-CP in the prospect-
ive sample. These scores were obtained by subtracting
Fig. 1 Flowchart of recruitment
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post- from pre-intervention results. A correlation matrix
was used to identify relationships between change scores
on the ASI, PAS, and CAQ subscales, and those on the
SF-MPQ-CP as well as age of participants. Variables sig-
nificantly correlated with change in chest pain intensity
were included in the first step of a hierarchical linear re-
gression analysis with change in SF-MPQ-CP scores as
the dependant variable. Sex was added as a potential
confounding variable in the second step.
Results
Participants
A total of 99 eligible patients were identified; 71 agreed
to participate in the study. Sixty-six patients completed
all baseline measures and were included in the sample.
Eighty-one percent (n = 53) of participants provided
post-intervention data and were included in the pro-
spective group (see Fig. 1). The sample with complete
post-intervention data was not significantly different
from the sample with incomplete post-intervention data
(see Table 1 for a summary of sample characteristics).
Relationships between CAQ subscales, AS, panic
symptoms, age and pain
Only the CAQ heart-focused attention subscale (r = 0.465;
p < 0.01) and heart-focused fear subscale (r = 0.270;
p < 0.05) scores were significantly correlated with SF-
MPQ-CP score (see Table 2). Together, these two variables
explained 19.5 % of the variance in SF-MPQ-CP score
(F (2, 63) = 8.857; p < 0.001). Sex did not significantly





Patients with missing post-intervention
data (n = 13)
p*
Mean age (SD) 41.76 (13.6) 41.45 (13.42) 43.00 (11.85) .705
Female, n (%)* 31 (47) 22 (42) 9 (69) .073
Married or common-law, n (%)** 38 (58) 31 (59) 7 (54) .761
Family income≥ $60,000, n (%)** 24 (36) 19 (36) 5 (39) 1.00
Education .343
≥ 12 years, n (%)** 36 (55) 29 (55) 9 (69)
Currently employed, n (%) 48 (73) 40 (75) 8 (62) .319
Comorbid psychiatric disorders, n (%) 44 (67) 34 (64) 10 (77) .522
Anxiety disorders, n (%) 43 (65) 34 (64) 9 (69) 1.00
Mood disorders, n (%) 10 (15) 6 (11) 6 (31) .103
CAQ – Heart-focused fear subscale
Baseline, mean (SD) 2.39 (0.75) 2.36 (0.77) 2.49 (0.69) .578
Mean change score (SD) - 0.85 (0.75) -
CAQ- Avoidance subscale
Baseline, mean (SD) 1.38 (0.98) 1.34 (0.92) 1.58 (1.24) .436
Mean change score (SD) - 0.32 (0.81) -
CAQ – Heart-focused attention subscale
Baseline, mean (SD) 1.87 (0.75) 1.84 (0.78) 1.98 (0.62) .568
Mean change score (SD) - 0.46 (0.85) -
PAS
Baseline, mean (SD) 19.62 (9.11) 19.17 (8.48) 21.46 (11.55) .421
Mean change score (SD) - 12.23 (8.56) -
ASI
Baseline, mean (SD) 28.98 (10.57) 28.72 (10.69) 30.08 (10.42) .681
Mean change score (SD) - 7.81 (11.53) -
SF-MPQ-CP
Baseline, mean (SD) 16.53 (10.99) 17.06 (10.41) 14.38 (13.39) .437
Mean change score (SD) - 7.32 (10.98) -
*p < 0.05 Prospective sample vs patients with missing post-intervention data
**Data was missing for some patients
CAQ cardiac anxiety questionnaire, PAS panic and agoraphobia scale, ASI anxiety sensitivity index, SF-MPQ-CP short-form McGill pain questionnaire, chest pain version
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contribute to the model (results not shown). See Table 3
for further details.
Relationships between changes in CAQ subscales, AS,
panic symptoms, age and changes in pain at post-
intervention
Change on all measures except the PAS were signifi-
cantly correlated with reduction in SF-MPQ-CP scores
(see Table 4). The multivariate model explained 20.3 %
of the variance in change in SF-MPQ-CP scores,
F(4,48) = 4.315; p < 0.01. However, only change in the
CAQ heart-focused fear subscale contributed signifi-
cantly to the model (p = 0.038) (see Table 3). Includ-
ing sex in the model did not significantly alter the
results (results not presented).
Discussion
The primary objective of this study was to evaluate the
association between AS, heart-focused fear, attention
and avoidance of cardiac symptoms, as well as panic
symptoms, and perceived chest pain level in patients
with PD and NCCP. The association between changes in
these psychological factors and reduction in pain scores
following evidence-based intervention for PD or usual
care was also assessed.
Of the variables evaluated in this study, only heart-
focused fear and attention for cardiac sensations (heart-
focused attention) were associated with NCCP intensity;
together, they explained 19.5 % of the variance in pain
scores. However, only the effect of attention was statisti-
cally significant.
The prospective analysis revealed that change in AS,
as well as in fear, attention, and avoidance of cardiac
sensations were correlated with changes in NCCP over a
period of 14 weeks of evidence-based intervention for
PD or usual care. However, only change in fear contrib-
uted significantly to change in chest pain intensity,
independently of other factors, explaining 20.3 % of its
variance.
At first glance, the absence of significant results for
avoidance, PD severity, and AS seems to contradict the-
oretical models of NCCP, as well as the literature in this
area [2, 10, 16]. However, although AS and PD symp-
toms have been shown to be related to NCCP, the rela-
tionships do not necessarily imply that these are relevant
in a sub-population of individuals who already present
PD and high levels of AS. In fact, the results of the cor-
relation matrix suggest that AS and PD symptoms could
indirectly contribute to NCCP through their strong rela-
tionship with heart-focused fear and heart-focused
avoidance. This hypothesis is consistent with Eifert and
colleagues (2000) who proposed that heart-focused anx-
iety, a construct comprising heart-focused fear, heart-
focused attention, and cardio-protective avoidance, is a
distinct construct of AS [15]. More specifically, AS may
be a predisposing factor for both PD and fear, attention
and avoidance of cardiac symptoms [15].
Furthermore, avoidance does not seem to contribute
to chest pain independently of its relationship with other
dimensions of heart-focused anxiety. There are two main
explanations for this finding. First, avoidance is generally
conceptualized as a response designed to manage fear of
symptoms [2, 15, 38]. This explanation is supported by
stronger correlations (r = 0.4 to 0.5) between change in
avoidance and change in AS, heart-focused attention,
and fear of cardiac symptoms than between change in
avoidance and change in reported pain (r = 0.3). Another
possibility is that avoidance contributes to pain-related
disability, rather than to pain itself. Furthermore, the ab-
sence of an effect of fear independent of the effect of
heart-focused attention on perceived pain may be ex-
plained by the central role of attention in pain percep-
tion [2, 15, 23]. That is, the role of fear may, in this
instance, be limited to increasing attention for chest
pain. This result is consistent with the literature suggest-
ing that fear of symptoms increases vigilance, thus pro-
moting greater perception and fear of symptoms while
maintaining and increasing attention [2, 15, 23].
In the prospective component of the study, only
change in heart-focused fear was related to change in
pain, independently of change in AS, heart-focused
avoidance, and heart-focused attention. This result sug-
gests a central role of fear in the experience of NCCP.
Furthermore, the observed inter-correlations indicate
that change in fear is the variable most strongly corre-
lated with change in all other variables. This result is
also consistent with the literature, and with models of
PD, NCCP and common vulnerability factors for pain
and anxiety [2, 39, 40].
The apparently contradictory results between the
cross-sectional and prospective components of the study
Table 2 Correlation matrix for CAQ subscales, ASI, PAS, SF-MPQ-CP
and age (n= 66)
Variables 1 2 3 4 5 6 7
1. CAQ – Fear Subscale 1
2. CAQ – Avoidance
subscale
.308* 1
3. CAQ – Attention
subscale
.460** .311* 1
4. PAS .264* .184 .327** 1
5. ASI .338** .126 .431** .456** 1
6. SF-MPQ-CP .270* .181 .464** .164 .162 1
7. Age .006 .058 .054 .000 -.075 -.194 1
* p < 0.05; ** p < 0.01
CAQ Cardiac Anxiety Questionnaire, PAS Panic and Agoraphobia Scale, ASI
Anxiety Sensitivity Index, SF-MPQ-CP Short-form McGill Pain Questionnaire, chest
pain version
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can be reconciled by highlighting the importance of
heart-focused attention and heart-focused fear in per-
ceived chest pain. Attention plays a central role in pain
perception. In fact, leading theoretical models for pain
suggest that change in pain is essentially attributable to
change in attention to pain [2, 15, 26].
The negative findings concerning the role of AS and
PD severity in determining pain severity in this sample
could be due to specific characteristics of patients with
PD and comorbid NCCP. Studies have shown that PD
severity and the level of AS are lower in PD patients
with comorbid NCCP than in patients with PD alone
[41, 42]. These characteristics are often interpreted as a
sign of a more recent onset of PD in ED patients with
NCCP than in other patients with PD. This said, one
could hypothesize that heart-focused anxiety would be
higher in patients with PD and NCCP, but, to our know-
ledge, no study has investigated this question yet.
Overall, the results of this study suggest that NCCP is
a condition independent of PD instead of a symptom of
this anxiety disorder. The results of this study also pro-
vide a possible explanation for the relatively weak effect
of intervention for PD on NCCP severity. Although PD
intervention generally reduces AS and fear of symptoms,
it appears that directly targeting fear of cardiac symp-
toms is essential for reducing NCCP intensity. This is
not surprising since chest pain is the defining symptom
of NCCP. However, none of the exposure exercises used
in cognitive-behavioural therapy reliably provoke chest
pain. Furthermore, modification of interpretation of
symptoms mostly addresses the link between symptoms
and anxiety, which may be insufficient to impact fear of
cardiac symptoms. In this case, the addition of a module
that more specifically targets heart-focused fear and
heart-focused attention could increase the efficacy of PD
intervention to reduce comorbid NCCP.
The present study has some limitations that must be
taken into consideration in interpreting the results. First,
some of our negative results may be attributable to the
limited sample size, particularly for the prospective com-
ponent of the study. Second, the present study addressed
AS, heart-focused attention, heart-focused fear, cardio-
protective avoidance, and PD in the context of NCCP.
However, NCCP and PD are also associated with other
psychological factors such as alexithymia and neuroti-
cism [16], which may constitute confounding factors.
Furthermore, although exploration of correlated factors
generates hypotheses for observed inter-relationships,
hypotheses can only be confirmed or disconfirmed by
more focused research designs.
The primary strengths of this study are the inclusion
of both cross-sectional and prospective components,
and the use of well validated measures. Finally, to our
knowledge, this is the first study to document variables
related to NCCP intensity and change in variables re-
lated to NCCP levels in a sample of PD patients.
Conclusions
Heart-focused fear and heart-focused attention explain a
significant portion of level of chest pain in PD patients
with NCCP. Decrease in fear of sensations seems to be a
Table 3 Multiple regression analysis predicting pain scores
B (95% CI) β sr2 Adjusted R2 ΔR2
Baseline scores (n = 66)
CAQ – Fear subscale 1.046 (-2.615- 4.708) 0.072 0.004 0.195 0.219*
CAQ – Attention subscale 6.344 (2.659- 10.029) 0.431 0.147*
Change scores (n = 53)
CAQ – Fear subscale 5.368 (0.312-10.425) 0.367** 0.070 0.203 0.264**
CAQ – Attention subscale 2.406 (-2.587- 7.399) 0.185 0.014
CAQ – Avoidance subscale -0.120 (-4.434- 4.194) -0.009 0.000
ASI 0.019 (-0.309- 0.347) 0.020 0.000
*p ≤ 0.001
**p = 0.005
CAQ Cardiac Anxiety Questionnaire, ASI Anxiety Sensitivity Index
Table 4 Correlation matrix for CAQ subscales, ASI, PAS, age and
SF-MPQ-CP change scores (n = 53)
Change scores 1 2 3 4 5 6 7
1. CAQ – Fear Subscale 1
2. CAQ – Avoidance
subscale
.504** 1
3. CAQ – Attention
subscale
.638** .595** 1
4. PAS .167 .400** .153 1
5. ASI .595** .453** .649** .179 1
6. SF-MPQ-CP .493** .295* .427** .215 .355** 1
7. Age .100 .059 .184 .128 -.021 .081 1
*p < 0.05; ** p < 0.01
CAQ Cardiac Anxiety Questionnaire, PAS Panic and Agoraphobia Scale, ASI
Anxiety Sensitivity Index, SF-MPQ-CP Short-form McGill Pain Questionnaire, chest
pain version
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central factor implicated in NCCP reduction. The efficacy
of intervention for patients with PD and NCCP could be
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